1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Advanz Pharma Services (UK) Limited

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

London UK

Primary Industry

Pharmaceuticals

About

Founded in 2018, and based in London, UK, Advanz Pharma Services (UK) Limited operates as a pharmaceutical company. It was formed via the merger between AMCO and Concordia International Corp. As of 2024, the company operates in more than 90 countries globally across Europe, the US, Canada, Australia, and India and is led by its CEO, Steffen Wagner. Advanz researches, develops, and retails medications by partnering with other biopharmaceutical and pharmaceutical development companies. As of 2024, the company’s product portfolio includes a range of medicines, treatments, specialty generics, biosimilars, specialty generics, and originators that are used to treat medical conditions in the fields of ophthalmology, endocrinology, urology, anti-infectives, intensive care, pain management, and central nervous system disorders.
Current Investors
Nordic Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.advanzpharma.com/
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only

Deals

Deals Type
Secondary Buyout
Add-on
Add-on
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Announced Advanz Pharma Services (UK) Limited 26 Feb 2024
Completed Sanofi's anti-infective portfolio 30 Sep 2022
Completed Intercept Pharmaceuticals, Inc.'s Business in Europe, Canada, and non U.S. 05 May 2022
Completed Advanz Pharma Services (UK) Limited 27 Jan 2021
Displaying 1-4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo